• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Management of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病管理。
Arch Razi Inst. 2022 Feb 28;77(1):439-447. doi: 10.22092/ARI.2021.356613.1882. eCollection 2022 Feb.
2
Medical students' knowledge about the management of chronic obstructive pulmonary disease in Nigeria.尼日利亚医学生对慢性阻塞性肺疾病管理的认知。
Int J Tuberc Lung Dis. 2014 Jan;18(1):117-21. doi: 10.5588/ijtld.13.0453.
3
Influence of risk factors on development of chronic obstructive pulmonary disease and legislative foundations for copd medical care in Ukraine.风险因素对慢性阻塞性肺疾病发展的影响及乌克兰慢性阻塞性肺疾病医疗的立法基础。
Wiad Lek. 2018;71(1 pt 2):222-225.
4
Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany.德国肺病专家基于指南对门诊 COPD 管理的调查。
Int J Chron Obstruct Pulmon Dis. 2012;7:101-8. doi: 10.2147/COPD.S27887. Epub 2012 Feb 14.
5
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease.最新技术纲要:加拿大胸科学会慢性阻塞性肺疾病管理指南
Can Respir J. 2004 Jul-Aug;11 Suppl B:7B-59B. doi: 10.1155/2004/946769.
6
Understanding of COPD among final-year medical students.医学专业最后一年学生对慢性阻塞性肺疾病(COPD)的了解。
Int J Chron Obstruct Pulmon Dis. 2017 Dec 28;13:131-139. doi: 10.2147/COPD.S138539. eCollection 2018.
7
Exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重
Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5.
8
Chronic obstructive pulmonary disease: role of bacteria and updated guide to antibacterial selection in the older patient.慢性阻塞性肺疾病:细菌的作用以及老年患者抗菌药物选择的最新指南。
Drugs Aging. 2009;26(12):985-95. doi: 10.2165/11315700-000000000-00000.
9
Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey.慢性阻塞性肺疾病和加重:来自全球“COPD 隐匿之深”调查的患者洞察。
BMC Pulm Med. 2013 Aug 23;13:54. doi: 10.1186/1471-2466-13-54.
10
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.低剂量茶碱口服联合吸入皮质激素治疗慢性阻塞性肺疾病且有加重高风险的患者:一项 RCT 研究。
Health Technol Assess. 2019 Jul;23(37):1-146. doi: 10.3310/hta23370.

引用本文的文献

1
The Effectiveness of Supplementation with Key Vitamins, Minerals, Antioxidants and Specific Nutritional Supplements in COPD-A Review.补充关键维生素、矿物质、抗氧化剂和特定营养补充剂对 COPD 的疗效-综述。
Nutrients. 2023 Jun 14;15(12):2741. doi: 10.3390/nu15122741.
2
N6-methyladenosine-methylomic landscape of lung tissues of mice with chronic obstructive pulmonary disease.N6-甲基腺苷甲基组学图谱揭示了慢性阻塞性肺疾病小鼠的肺部组织特征。
Front Immunol. 2023 Mar 28;14:1137195. doi: 10.3389/fimmu.2023.1137195. eCollection 2023.

本文引用的文献

1
Outdoor air pollution from industrial chemicals causing new onset of asthma or COPD: a systematic review protocol.工业化学品造成的室外空气污染导致新发哮喘或慢性阻塞性肺疾病:一项系统评价方案
J Occup Med Toxicol. 2020 Dec 28;15(1):38. doi: 10.1186/s12995-020-00289-6.
2
Smoking Cessation During the COVID-19 Epidemic.新冠疫情期间的戒烟
Nicotine Tob Res. 2020 Aug 24;22(9):1664-1665. doi: 10.1093/ntr/ntaa075.
3
Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation.疲劳在 COPD 患者中非常普遍,与气流受限程度相关性差。
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619878128. doi: 10.1177/1753466619878128.
4
Choosing the right inhaler for your asthma or COPD patient.为您的哮喘或慢性阻塞性肺疾病患者选择合适的吸入器。
Ther Clin Risk Manag. 2019 Mar 14;15:461-472. doi: 10.2147/TCRM.S160365. eCollection 2019.
5
Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.流感疫苗对 COPD 住院患者住院和严重结局风险因素的有效性。
Chest. 2019 Jan;155(1):69-78. doi: 10.1016/j.chest.2018.10.044.
6
Pneumococcal vaccination and chronic respiratory diseases.肺炎球菌疫苗接种与慢性呼吸系统疾病。
Int J Chron Obstruct Pulmon Dis. 2017 Dec 5;12:3457-3468. doi: 10.2147/COPD.S140378. eCollection 2017.
7
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary: a brief history of time.慢性阻塞性肺疾病全球倡议(GOLD)20周年:时间简史
Eur Respir J. 2017 Jul 5;50(1). doi: 10.1183/13993003.00671-2017. Print 2017 Jul.
8
The Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的药物治疗
Dtsch Arztebl Int. 2016 May 6;113(18):311-6. doi: 10.3238/arztebl.2016.0311.
9
Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement.慢性阻塞性肺疾病筛查:美国预防服务工作组推荐声明。
JAMA. 2016 Apr 5;315(13):1372-7. doi: 10.1001/jama.2016.2638.
10
Exacerbations of COPD.慢性阻塞性肺疾病急性加重
Int J Chron Obstruct Pulmon Dis. 2016 Feb 19;11 Spec Iss(Spec Iss):21-30. doi: 10.2147/COPD.S85978. eCollection 2016.

慢性阻塞性肺疾病管理。

Management of Chronic Obstructive Pulmonary Disease.

机构信息

Belgorod State National Research University, 85 Pobedy St., Belgorod 308015 Russia.

Voronezh State Medical University named after N.N. Burdenko, 10 Studencheskaya St., Voronezh 394036 Russia.

出版信息

Arch Razi Inst. 2022 Feb 28;77(1):439-447. doi: 10.22092/ARI.2021.356613.1882. eCollection 2022 Feb.

DOI:10.22092/ARI.2021.356613.1882
PMID:35891752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9288591/
Abstract

The relevance of the study of chronic obstructive pulmonary disease (COPD) can be explained by the persistence of unfavorable dynamics of the disease, even despite the achieved success in the pharmacotherapy of this pathology. In 2016, World Health Organization (WHO) ranked COPD as the third leading cause of death worldwide, far exceeding the experts' predictions, who believed that such an increase in the death rate would occur by 2030. This study aimed to determine the level of senior medical students' knowledge in the management of patients with COPD, based on the method of anonymous questioning. This research work describes the results of the second stage of the ASCO project (Assessment of Senior Medical Students in the Field of COPD) conducted in 2017-2019 among 338 senior medical students from six large cities of Russia and Ukraine. The survey revealed the average level of knowledge among senior medical students, based on the average level of correct answers (56.6%) obtained in the study. The best results were obtained for the questions about COPD risk factors, influenza vaccine prevention, and pneumococcal vaccine prevention in COPD patients. The worst results were recorded on the questions about the severity of COPD clinical symptoms, the choice of initial therapy for COPD with advanced symptoms, a high risk of exacerbations, and the moderate exacerbation of COPD. The obtained results indicated an insufficient level of students' basic knowledge in questions regarding etiopathogenesis, diagnosis, treatment, and prevention of COPD.

摘要

慢性阻塞性肺疾病(COPD)研究的相关性可以用该疾病的不利动态持续来解释,尽管在这种病理的药物治疗方面已经取得了成功。2016 年,世界卫生组织(WHO)将 COPD 列为全球第三大死亡原因,远远超出了专家的预测,专家们认为这种死亡率的增加将在 2030 年发生。本研究旨在基于匿名提问的方法,确定高年级医学生在 COPD 患者管理方面的知识水平。这项研究工作描述了 2017 年至 2019 年在俄罗斯和乌克兰的六个大城市的 338 名高年级医学生中进行的 ASCO 项目(COPD 高年级医学生评估)第二阶段的结果。该调查根据研究中获得的平均正确答案(56.6%)得出了高年级医学生的平均知识水平。在 COPD 风险因素、流感疫苗预防和 COPD 患者中肺炎球菌疫苗预防的问题上,取得了最好的结果。在 COPD 临床症状严重程度、晚期 COPD 初始治疗选择、高恶化风险和 COPD 中度恶化等问题上,记录的结果最差。所获得的结果表明,学生在 COPD 的病因学、诊断、治疗和预防方面的基础知识水平不足。